We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

124 hedge funds and large institutions have $119M invested in Ventyx Biosciences in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 27 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 27

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

5% more funds holding

Funds holding: 118 → 124 (+6)

2.74% more ownership

Funds ownership: 74.26% → 77% (+2.7%)

4% more capital invested

Capital invested by funds: $114M → $119M (+$4.83M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

43% less call options, than puts

Call options by funds: $232K | Put options by funds: $408K

Holders
124
Holders Change
+6
Holders Change %
+5.08%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
45
Reduced
27
Closed
20
Calls
$232K
Puts
$408K
Net Calls
-$176K
Net Calls Change
-$202K

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$7.65M
2
UBS Group
UBS Group
Switzerland
+$5.86M
3
Morgan Stanley
Morgan Stanley
New York
+$4.94M
4
SCM
Sio Capital Management
New York
+$4.7M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$14M
2
FCM
Farallon Capital Management
California
-$6.91M
3
OCA
Octagon Capital Advisors
New York
-$5.21M
4
RG
Redmile Group
California
-$4.49M
5
Goldman Sachs
Goldman Sachs
New York
-$961K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.04M +$479K +211,421 +80%
Macquarie Group
27
Macquarie Group
Australia
$942K – – –
QUSVM
28
Qiming U.S. Ventures Management
Washington
$903K – – –
WC
29
Wexford Capital
Florida
$873K -$115K -50,583 -11%
TCM
30
TCG Crossover Management
California
$692K – – –
BFM
31
Boothbay Fund Management
New York
$690K +$589K +259,863 +472%
OM
32
Opaleye Management
Massachusetts
$613K +$635K +280,000 New
UOC
33
UBS O'Connor
Illinois
$534K +$99.7K +44,000 +22%
MAM
34
Monaco Asset Management
Monaco
$526K +$544K +240,000 New
WP
35
Woodline Partners
California
$467K +$483K +213,240 New
BCM
36
Bridgeway Capital Management
Texas
$450K +$12.5K +5,500 +3%
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
$436K +$451K +198,947 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$388K +$1.48K +651 +0.4%
N
39
Nuveen
North Carolina
$369K – – –
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$347K +$359K +158,288 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$334K +$197K +86,899 +132%
Simplex Trading
42
Simplex Trading
Illinois
$327K +$339K +149,554 New
Invesco
43
Invesco
Georgia
$319K -$2.33K -1,030 -0.7%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$291K +$92.5K +40,813 +44%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$276K +$286K +126,143 New
SC
46
Shay Capital
New York
$273K +$282K +124,615 New
ACM
47
ADAR1 Capital Management
Texas
$273K +$60.2K +26,575 +27%
RG
48
Redmile Group
California
$272K -$4.49M -1,983,037 -94%
HighTower Advisors
49
HighTower Advisors
Illinois
$228K +$750 +331 +0.3%
AllianceBernstein
50
AllianceBernstein
Tennessee
$222K – – –
1
2
3 4 5

VTYX Hedge Fund Activity: Q4 2024 in Review

124 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2024, worth a combined $119M — up 4.2% from $114M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VTYX positions and 20 closed out — a net gain of 8 holders — while 45 added to existing stakes and 27 trimmed.

The largest buyer was Bank of America, adding an estimated $7.65M. The largest seller was Deerfield Management, cutting an estimated $14M.

  • 124 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2024, up from 118 in Q3 2024.
  • Funds reported $119M of Ventyx Biosciences stock for Q4 2024, up 4.2% quarter-over-quarter.
  • 28 funds opened new Ventyx Biosciences positions in Q4 2024 and 20 closed out, a net change of +8 holders.
  • The largest Ventyx Biosciences buyer in Q4 2024 was Bank of America, an estimated $7.65M added.
  • The largest Ventyx Biosciences seller in Q4 2024 was Deerfield Management, an estimated $14M sold.

Based on aggregated 13F filings for Q4 2024.